TRS: Hold with a $37.15 price target

Year-to-date profit has improved, but quarterly profit fell.

Target for 2027-09-17: $37.15 USD, -3.1% versus the $38.34 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.

Over 1 year (2025-09-12 to 2026-09-11), price changed -1.7% and trailing EPS changed -8.3%. A wider gap changes the earnings multiple; it does not establish fair value.

Across 2 completed quarters since 2025-12-31, net income was 814.2m versus 29.1m in the matching prior-year periods (USD). Non-operating income is material to the latest year's profit. This increase does not establish recurring earnings growth.

Net debt / EBITDA: -12.7× for TRS, against 2.8× across 12 comparable peers.

Net income was 13.4m, compared with 16.7m in the same quarter last year. Amounts are in USD.

Dividends and buybacks totalled 180.8m versus -11.4m of cash after capital spending over four quarters. Existing cash or borrowing can fund a difference.

The latest quarterly margin changed +1.9 percentage points from a year earlier. Check sales volumes, pricing and unusual gains in the next filing.

Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.

Compare the stock and the market fund over the same dates. Look for a change in relative performance as results arrive.

Starting annual sales growth: 4.29%.

Long-term operating margin: 7.08%.

Review recorded on 2026-09-17. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.